Notably, the combination group demonstrated a positive trend, marked by a more pronounced tumor growth inhibition ( figure 5C ), although complete responses were not observed.
← all excerpts
An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade.
1
—
—